Annual Working Capital:
-$13.17B-$8.33B(-172.10%)Summary
- As of today, ABBV annual working capital is -$13.17 billion, with the most recent change of -$8.33 billion (-172.10%) on December 31, 2024.
- During the last 3 years, ABBV annual working capital has fallen by -$5.90 billion (-81.21%).
- ABBV annual working capital is now -138.80% below its all-time high of $33.93 billion, reached on December 31, 2019.
Performance
ABBV Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Working Capital:
-$10.51B-$1.78B(-20.37%)Summary
- As of today, ABBV quarterly working capital is -$10.51 billion, with the most recent change of -$1.78 billion (-20.37%) on June 30, 2025.
- Over the past year, ABBV quarterly working capital has dropped by -$2.41 billion (-29.72%).
- ABBV quarterly working capital is now -129.77% below its all-time high of $35.29 billion, reached on March 31, 2020.
Performance
ABBV Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ABBV Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -172.1% | -29.7% |
| 3Y3 Years | -81.2% | -95.5% |
| 5Y5 Years | -138.8% | -209.9% |
ABBV Working Capital Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -1124.8% | at low | -877.3% | +31.2% |
| 5Y | 5-Year | -138.8% | at low | -2577.8% | +31.2% |
| All-Time | All-Time | -138.8% | at low | -129.8% | +31.2% |
ABBV Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -$10.51B(-20.4%) |
| Mar 2025 | - | -$8.73B(+33.7%) |
| Dec 2024 | -$13.17B(-172.1%) | -$13.17B(+13.8%) |
| Sep 2024 | - | -$15.28B(-88.6%) |
| Jun 2024 | - | -$8.10B(-205.5%) |
| Mar 2024 | - | -$2.65B(+45.2%) |
| Dec 2023 | -$4.84B(-350.1%) | -$4.84B(-212.4%) |
| Sep 2023 | - | -$1.55B(+54.3%) |
| Jun 2023 | - | -$3.39B(-207.4%) |
| Mar 2023 | - | -$1.10B(-2.5%) |
| Dec 2022 | -$1.07B(+85.2%) | -$1.07B(+54.2%) |
| Sep 2022 | - | -$2.35B(+56.3%) |
| Jun 2022 | - | -$5.37B(+10.6%) |
| Mar 2022 | - | -$6.01B(+17.3%) |
| Dec 2021 | -$7.27B(-61.9%) | -$7.27B(-1813.7%) |
| Sep 2021 | - | $424.00M(+115.8%) |
| Jun 2021 | - | -$2.69B(+50.1%) |
| Mar 2021 | - | -$5.38B(-19.9%) |
| Dec 2020 | -$4.49B(-113.2%) | -$4.49B(-282.9%) |
| Sep 2020 | - | -$1.17B(+65.4%) |
| Jun 2020 | - | -$3.39B(-109.6%) |
| Mar 2020 | - | $35.29B(+4.0%) |
| Dec 2019 | $33.93B(>+9900.0%) | $33.93B(+1169.5%) |
| Sep 2019 | - | $2.67B(+245.2%) |
| Jun 2019 | - | -$1.84B(-461.7%) |
| Mar 2019 | - | $509.00M(+273.1%) |
| Dec 2018 | -$294.00M | -$294.00M(-109.6%) |
| Sep 2018 | - | $3.08B(+191.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | -$3.38B(-199.8%) |
| Mar 2018 | - | $3.39B(-26.1%) |
| Dec 2017 | $4.58B(-28.5%) | $4.58B(-22.3%) |
| Sep 2017 | - | $5.90B(+25.4%) |
| Jun 2017 | - | $4.70B(-29.8%) |
| Mar 2017 | - | $6.70B(+4.6%) |
| Dec 2016 | $6.41B(+18.2%) | $6.41B(-10.9%) |
| Sep 2016 | - | $7.19B(-4.4%) |
| Jun 2016 | - | $7.52B(+26.2%) |
| Mar 2016 | - | $5.96B(+10.0%) |
| Dec 2015 | $5.42B(+15.6%) | $5.42B(-40.4%) |
| Sep 2015 | - | $9.10B(+61.9%) |
| Jun 2015 | - | $5.62B(+28.9%) |
| Mar 2015 | - | $4.36B(-7.0%) |
| Dec 2014 | $4.69B(-57.3%) | $4.69B(-57.1%) |
| Sep 2014 | - | $10.92B(-4.9%) |
| Jun 2014 | - | $11.48B(+3.3%) |
| Mar 2014 | - | $11.11B(+1.3%) |
| Dec 2013 | $10.97B(+27.9%) | $10.97B(+13.5%) |
| Sep 2013 | - | $9.67B(+9.2%) |
| Jun 2013 | - | $8.86B(+8.6%) |
| Mar 2013 | - | $8.16B(-4.9%) |
| Dec 2012 | $8.58B(+488.6%) | $8.58B(+54.2%) |
| Sep 2012 | - | $5.56B(+382.4%) |
| Jun 2012 | - | $1.15B(-6.7%) |
| Mar 2012 | - | $1.24B(-15.2%) |
| Dec 2011 | $1.46B(-67.3%) | $1.46B |
| Dec 2010 | $4.46B | - |
FAQ
- What is AbbVie Inc. annual working capital?
- What is the all-time high annual working capital for AbbVie Inc.?
- What is AbbVie Inc. annual working capital year-on-year change?
- What is AbbVie Inc. quarterly working capital?
- What is the all-time high quarterly working capital for AbbVie Inc.?
- What is AbbVie Inc. quarterly working capital year-on-year change?
What is AbbVie Inc. annual working capital?
The current annual working capital of ABBV is -$13.17B
What is the all-time high annual working capital for AbbVie Inc.?
AbbVie Inc. all-time high annual working capital is $33.93B
What is AbbVie Inc. annual working capital year-on-year change?
Over the past year, ABBV annual working capital has changed by -$8.33B (-172.10%)
What is AbbVie Inc. quarterly working capital?
The current quarterly working capital of ABBV is -$10.51B
What is the all-time high quarterly working capital for AbbVie Inc.?
AbbVie Inc. all-time high quarterly working capital is $35.29B
What is AbbVie Inc. quarterly working capital year-on-year change?
Over the past year, ABBV quarterly working capital has changed by -$2.41B (-29.72%)